$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb

$lsb Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 20-F Financial Statement

#000121390024069344 Filed on August 15, 2024

Income Statement

Concept	2024 Q1	2024	2023 Q1
Revenue	$300.3M	$80.82M	$687.2M
YoY Change	-56.3%	-19.18%
Cost Of Revenue	$65.50M	$16.59M	$153.4M
YoY Change	-57.29%	-25.68%
Gross Profit	$234.8M	$64.23M	$533.8M
YoY Change	-56.01%	-17.32%
Gross Profit Margin	78.19%	79.48%	77.68%
Selling, General & Admin	$216.0M	$62.21M	$354.5M
YoY Change	-39.06%	20.57%	151599.88%
% of Gross Profit	92.0%	96.84%	66.41%
Research & Development	$123.9M	$42.68M	$318.7M
YoY Change	-61.11%	-7.98%
% of Gross Profit	52.78%	66.44%	59.7%
Depreciation & Amortization	$22.25M	$4.986M	$19.50M
YoY Change	14.11%	15.22%	19.63%
% of Gross Profit	9.48%	7.76%	3.65%
Operating Expenses	$340.0M	$127.1M	$673.2M
YoY Change	-49.5%	29.7%	-3124105.38%
Operating Profit	-$105.2M	-$62.84M	-$139.4M
YoY Change	-24.55%	209.8%
Interest Expense	-$31.38M	-$44.34M	-$30.86M
YoY Change	1.68%	43.71%	-526.63%
% of Operating Profit
Other Income/Expense, Net	$14.10M	-$1.319M	$25.89M
YoY Change	-45.55%	82.67%	-20388.66%
Pretax Income	-$279.9M	-$64.16M	-$144.3M
YoY Change	93.88%	205.42%	-2125.38%
Income Tax	-$20.91M	-$3.063M	$1.134M
% Of Pretax Income
Net Earnings	-$258.9M	-433.5M cnies	-$283.5M
YoY Change	-8.65%	1947.47%	-4077.51%
Net Earnings / Revenue	-86.22%	-536.33%	-41.25%
Basic Earnings Per Share		-$0.57
Diluted Earnings Per Share	-$2.14	-$4.05	-$3.05
COMMON SHARES
Basic Shares Outstanding	190.2M shares	106.9M shares	93.06M shares
Diluted Shares Outstanding		106.9M shares

Balance Sheet

Concept	2024 Q1	2024	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$246.4M	$250.4M	$374.4M
YoY Change	-34.21%	-33.13%	51890.76%
Cash & Equivalents	$34.75M		$53.90M
Short-Term Investments		$4.043M	$4.340M
Other Short-Term Assets	$9.233M	$2.196M	$131.2K
YoY Change	6938.88%	-72.76%	106.79%
Inventory	$28.67M	$203.4M	$26.98M
Prepaid Expenses
Receivables	$62.60M	$444.2M	$67.39M
Other Receivables	$0.00	$2.993M	$5.035M
Total Short-Term Assets	$127.3M	$903.2M	$150.8M
YoY Change	-15.56%	-12.82%	19138.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.72M	$480.6M	$83.20M
YoY Change	-19.82%	-17.54%	-84.88%
Goodwill
YoY Change
Intangibles	$10.04M		$11.36M
YoY Change	-11.6%		-85.93%
Long-Term Investments
YoY Change
Other Assets	$4.842M	$57.99M	$3.045M
YoY Change	59.03%	154.02%	-89.21%
Total Long-Term Assets	$85.96M	$609.9M	$99.51M
YoY Change	-13.62%	-10.81%	-50.25%
TOTAL ASSETS
Total Short-Term Assets	$127.3M	$903.2M	$150.8M
Total Long-Term Assets	$85.96M	$609.9M	$99.51M
Total Assets	$213.3M	$1.513B	$250.3M
YoY Change	-14.79%	-12.02%	24.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.552M	$67.77M	$11.71M
YoY Change	-18.4%	-15.74%	-62.01%
Accrued Expenses	$413.9M	$280.8M	$266.2M
YoY Change	55.5%	5.51%	199862.02%
Deferred Revenue
YoY Change
Short-Term Debt	$44.90M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$318.5M	$318.5M	$193.7M
YoY Change	64.42%	64.42%
Total Short-Term Liabilities	$113.1M	$802.2M	$95.87M
YoY Change	17.95%	21.78%	71920.09%
LONG-TERM LIABILITIES
Long-Term Debt	$13.95M	$98.98M	$42.75M
YoY Change	-67.37%	-66.31%
Other Long-Term Liabilities	$26.61M	$26.61M	$38.75M
YoY Change	-31.32%	-31.32%	201.09%
Total Long-Term Liabilities	$13.95M	$125.6M	$48.39M
YoY Change	-71.17%	-62.23%	276.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$113.1M	$802.2M	$95.87M
Total Long-Term Liabilities	$13.95M	$125.6M	$48.39M
Total Liabilities	$130.8M	$927.8M	$144.3M
YoY Change	-9.35%	-6.4%	1009.5%
SHAREHOLDERS EQUITY
Retained Earnings	-2.308B cnies		-1.874B cnies
YoY Change	23.13%		17.82%
Common Stock	$415.9M		$1.790K
YoY Change	23235155.08%		-77.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$82.48M	$585.2M	728.5M cnies
YoY Change
Total Liabilities & Shareholders Equity	$213.3M	$1.513B	$250.3M
YoY Change	-14.79%	-12.02%	24.63%

Cashflow Statement

Concept	2024 Q1	2024	2023 Q1
OPERATING ACTIVITIES
Net Income	-$258.9M	-433.5M cnies	-$283.5M
YoY Change	-8.65%	1947.47%	-4077.51%
Depreciation, Depletion And Amortization	$22.25M	$4.986M	$19.50M
YoY Change	14.11%	15.22%	19.63%
Cash From Operating Activities	-$149.4M	-$41.61M	-$75.10M
YoY Change	98.93%	56.7%	45420.67%
INVESTING ACTIVITIES
Capital Expenditures	$20.67M	$6.237M	$38.00M
YoY Change	-45.6%	-18.77%	-60.21%
Acquisitions
YoY Change
Other Investing Activities	-$155.2K	$0.00	$100.0K
YoY Change	-255.19%	-100.0%
Cash From Investing Activities	-$20.83M	-$6.237M	-$38.00M
YoY Change	-45.19%	-24.79%	-60.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$40.06M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	160.4M	$28.93M	265.5M
YoY Change	-39.58%	-37.38%	-17.21%
NET CHANGE
Cash From Operating Activities	-149.4M	-$41.61M	-75.10M
Cash From Investing Activities	-20.83M	-$6.237M	-38.00M
Cash From Financing Activities	160.4M	$28.93M	265.5M
Net Change In Cash	-9.821M	-$17.45M	152.4M
YoY Change	-106.44%	-220.76%	-92474.83%
FREE CASH FLOW
Cash From Operating Activities	-$149.4M	-$41.61M	-$75.10M
Capital Expenditures	$20.67M	$6.237M	$38.00M
Free Cash Flow	-$170.1M	-$47.85M	-$113.1M
YoY Change	50.37%	39.78%	18.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-41598
CY2024	dei	Entity Registrant Name EntityRegistrantName	LakeShore Biopharma Co., Ltd
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building No. 2
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	38 Yongda Road
CY2024	dei	Entity Address Address Line3 EntityAddressAddressLine3	Daxing Biomedical Industry ParkDaxing District
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	102629
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	190227959	shares
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	dei	Auditor Firm AuditorFirmId	2388
CY2024	dei	Auditor Name AuditorName	Wei, Wei & Co., LLP
CY2024	dei	Auditor Location AuditorLocation	Flushing, New York
CY2023Q1	us-gaap	Cash Cash	370108059	cny
CY2024Q1	us-gaap	Cash Cash	246351231	cny
CY2024Q1	us-gaap	Cash Cash	34721808	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	261766	cny
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	cny
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	28189	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	463051792	cny
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	444161291	cny
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62602014	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	6763326	cny
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1662739	cny
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	234354	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	185380952	cny
CY2024Q1	us-gaap	Inventory Net InventoryNet	203422602	cny
CY2024Q1	us-gaap	Inventory Net InventoryNet	28671262	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10412769	cny
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7370089	cny
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1038772	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1035978664	cny
CY2024Q1	us-gaap	Assets Current AssetsCurrent	903167952	cny
CY2024Q1	us-gaap	Assets Current AssetsCurrent	127296399	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	571756443	cny
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	473348006	cny
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66715716	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11132428	cny
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7275367	cny
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1025422	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1905581	cny
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	23634189	cny
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3331105	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78056792	cny
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	71245336	cny
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10041626	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20923703	cny
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34356506	cny
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4842355	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	683774947	cny
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	609859404	cny
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	85956224	usd
CY2023Q1	us-gaap	Assets Assets	1719753611	cny
CY2024Q1	us-gaap	Assets Assets	1513027356	cny
CY2024Q1	us-gaap	Assets Assets	213252623	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	193736563	cny
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	318540732	cny
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	44896509	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	80439489	cny
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	67774798	cny
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	9552473	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	377536644	cny
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	408737969	cny
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	57609301	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4753547	cny
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5156540	cny
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	726785	usd
CY2023Q1	us-gaap	Government Assistance Liability Current GovernmentAssistanceLiabilityCurrent	2295701	cny
CY2024Q1	us-gaap	Government Assistance Liability Current GovernmentAssistanceLiabilityCurrent	2015693	cny
CY2024Q1	us-gaap	Government Assistance Liability Current GovernmentAssistanceLiabilityCurrent	284100	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	658761944	cny
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	802225732	cny
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	113069168	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	293790596	cny
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	98983780	cny
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13951202	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6348890	cny
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1783593	cny
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	251387	usd
CY2023Q1	us-gaap	Government Assistance Liability Noncurrent GovernmentAssistanceLiabilityNoncurrent	23606507	cny
CY2024Q1	us-gaap	Government Assistance Liability Noncurrent GovernmentAssistanceLiabilityNoncurrent	20279945	cny
CY2024Q1	us-gaap	Government Assistance Liability Noncurrent GovernmentAssistanceLiabilityNoncurrent	2858343	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8792389	cny
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4548004	cny
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	641015	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	332538382	cny
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	125595322	cny
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17701947	usd
CY2023Q1	us-gaap	Liabilities Liabilities	991300326	cny
CY2024Q1	us-gaap	Liabilities Liabilities	927821054	cny
CY2024Q1	us-gaap	Liabilities Liabilities	130771115	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00002
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9950000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93058197	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93058197	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190227959	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190227959	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190227959	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190227959	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12297	cny
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	26105	cny
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	3679	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2656891036	cny
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2950862914	cny
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	415907387	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1874037965	cny
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2307502836	cny
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-325229434	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54412083	cny
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-58179881	cny
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8200124	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	728453285	cny
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	585206302	cny
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	82481508	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1719753611	cny
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1513027356	cny
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	213252623	usd
CY2022	us-gaap	Revenues Revenues	502949894	cny
CY2023	us-gaap	Revenues Revenues	687201070	cny
CY2024	us-gaap	Revenues Revenues	573418256	cny
CY2024	us-gaap	Revenues Revenues	80820050	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	117066090	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	153360262	cny
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	117688301	cny
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	16587498	usd
CY2022	us-gaap	Gross Profit GrossProfit	385883804	cny
CY2023	us-gaap	Gross Profit GrossProfit	533840808	cny
CY2024	us-gaap	Gross Profit GrossProfit	455729955	cny
CY2024	us-gaap	Gross Profit GrossProfit	64232552	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	185999704	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	272927356	cny
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	301259528	cny
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42460821	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	98144146	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	72939790	cny
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	140086062	cny
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19744336	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	9476354	cny
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	8655487	cny
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	157415875	cny
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	22186875	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	211222263	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	318700526	cny
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	302800992	cny
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42678082	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	504842467	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	673223159	cny
CY2024	us-gaap	Operating Expenses OperatingExpenses	901562457	cny
CY2024	us-gaap	Operating Expenses OperatingExpenses	127070114	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-118958663	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-139382351	cny
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-445832502	cny
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-62837562	usd
CY2022	lsb	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	231231	cny
CY2023	lsb	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax	3603	cny
CY2022	lsb	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	1852378	cny
CY2023	lsb	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	747609	cny
CY2024	lsb	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	756201	cny
CY2024	lsb	Late Fees Related To Social Security Insurance LateFeesRelatedToSocialSecurityInsurance	106582	usd
CY2022	us-gaap	Government Assistance Nonoperating Income GovernmentAssistanceNonoperatingIncome	23020413	cny
CY2023	us-gaap	Government Assistance Nonoperating Income GovernmentAssistanceNonoperatingIncome	26072517	cny
CY2024	us-gaap	Government Assistance Nonoperating Income GovernmentAssistanceNonoperatingIncome	20708778	cny
CY2024	us-gaap	Government Assistance Nonoperating Income GovernmentAssistanceNonoperatingIncome	2918785	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2717433	cny
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30857673	cny
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-44344808	cny
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6250149	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21358	cny
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4458844	cny
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-628449	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-327987	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	551760	cny
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10572411	cny
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1490121	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17891384	cny
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4963250	cny
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9360976	cny
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1319376	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-101067279	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-144345601	cny
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-455193478	cny
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64156938	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4937122	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1133504	cny
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21728607	cny
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3062524	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-433464871	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-61094414	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	130662326	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	137991697	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236666727	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-283470802	cny
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-433464871	cny
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-61094414	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-433464871	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-61094414	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	38864606	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-137500063	cny
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3767798	cny
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-531050	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-67139795	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-282979168	cny
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-437232669	cny
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61625464	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.35
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.05
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61827883	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61785466	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106923121	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106923121	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-508862707	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	130662326	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	7764448	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	38795798	cny
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-698969188	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	137991697	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1636897084	cny
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3505001	cny
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	216378193	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8870007	cny
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	483066	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-137500062	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	728453285	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-433464871	cny
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	9789686	cny
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	284196000	cny
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-3767798	cny
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	585206302	cny
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	82481508	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-433464871	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-61094414	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4937120	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1133504	cny
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21728608	cny
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3062524	usd
CY2022	us-gaap	Depreciation Depreciation	24475736	cny
CY2023	us-gaap	Depreciation Depreciation	29735024	cny
CY2024	us-gaap	Depreciation Depreciation	35373927	cny
CY2024	us-gaap	Depreciation Depreciation	4985754	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6678233	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6952783	cny
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6811456	cny
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	960036	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-273982	cny
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-13135	cny
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1851	usd
CY2024	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	80236996	cny
CY2024	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	11308949	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7764448	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3505001	cny
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9789686	cny
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1379801	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5084924	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10750949	cny
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4987206	cny
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	702918	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4393630	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-723583	cny
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	68221017	cny
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	9615365	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	3787628	cny
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	4423612	cny
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	4778623	cny
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	673520	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21358	cny
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4458844	cny
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-628449	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	89459313	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18151804	cny
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	86262667	cny
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12158234	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	99137291	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165247635	cny
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13903295	cny
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1959591	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-30088833	cny
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-59229802	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8992573	cny
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5289535	cny
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	745530	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14427864	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	49628389	cny
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12664691	cny
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1785016	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-35633487	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	43029496	cny
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	53220366	cny
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	7501109	usd
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	656673	cny
CY2023	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	6447010	cny
CY2024	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	3606570	cny
CY2024	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	508326	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3796392	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4550232	cny
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5089524	cny
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-717340	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-173545357	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-182469396	cny
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-295229603	cny
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41610939	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	cny
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	68001	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	295314351	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52758124	cny
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44250714	cny
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6236887	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3617607	cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4291597	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-298923958	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56981720	cny
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44250714	cny
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6236887	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	284196000	cny
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40055814	usd
CY2023	lsb	Proceeds From Business Combination ProceedsFromBusinessCombination	252457329	cny
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	35884661	cny
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	414116587	cny
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	247387392	cny
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	337851075	cny
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	47618192	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	49558442	cny
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	146510134	cny
CY2024	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	416785723	cny
CY2024	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	58743583	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	364558145	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	317449926	cny
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	205261352	cny
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28930423	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-11478411	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21303512	cny
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10400371	cny
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1465874	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-119389581	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	99302322	cny
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-123818594	cny
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17451529	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	390457084	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271067503	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	370369825	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52201526	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271067503	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	370369825	cny
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246551231	cny
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34749997	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2404357	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	27289057	cny
CY2024	us-gaap	Interest Paid Net InterestPaidNet	30131238	cny
CY2024	us-gaap	Interest Paid Net InterestPaidNet	4246827	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	130662326	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	137991697	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1516478	cny
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	331218	cny
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	829703	cny
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	116942	usd
CY2023	lsb	Equity Transaction From Warrants EquityTransactionFromWarrants	-8870007	cny
CY2023	us-gaap	Stock Issued1 StockIssued1	1636897084	cny
CY2024	lsb	Number Of Companies And Their Subsidiaries Owned NumberOfCompaniesAndTheirSubsidiariesOwned	4	pure
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-106004401	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-145479105	cny
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-433464871	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1874037965	cny
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2307502836	cny
CY2024Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	417500000	cny
CY2024Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	58800000	usd
CY2023Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	40000000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	3100000	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	95269762	shares
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Reclassification</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Certain prior year amounts have been reclassified to conform with the current year presentation, as follows (in RMB).</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Previously reported</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Decrease)/<br/> Increase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Reclassified)</td><td> </td></tr> <tr style="vertical-align: bottom"> <td>Consolidated Statements of Operations and Comprehensive Loss</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 0.25in">General and administrative</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">81,595,277</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(8,655,487</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">72,939,790</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Impairment loss on inventory, property, plant and equipment and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,655,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,655,487</td><td style="text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Previously reported</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,<br/> 2022</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>(Decrease)/<br/> Increase</b></td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,<br/> 2022</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Reclassified)</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td>Consolidated Statements of Operations and Comprehensive Loss</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 64%; text-align: left">General and administrative</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"></td> <td style="width: 9%; text-align: right">107,620,500</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"></td> <td style="width: 9%; text-align: right">(9,476,354</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"></td> <td style="width: 9%; text-align: right">98,144,146</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Impairment loss on inventory, property, plant and equipment and other assets</td> <td> </td> <td style="text-align: left"></td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"></td> <td style="text-align: right">9,476,354</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"></td> <td style="text-align: right">9,476,354</td> <td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; ">These reclassifications had no effect on the reported results of operations.</p><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p>
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	72939790	cny
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	8655487	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	98144146	cny
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	9476354	cny
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the CFS in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions reflected in these CFS include, but are not limited to, the valuation of Lakeshore Group’s convertible redeemable preferred shares and ordinary shares, accrual of stock-based compensation expense, allowance for estimated credit losses and obsolete inventories, useful life of property, plant and equipment, income taxes and uncertain tax positions. Actual amounts could differ from those estimates. Changes in estimates are recorded in the period when they become known. Due to the risks and uncertainties involved in Lakeshore Group’s business and evolving market conditions and, given the subjective element of the estimates and assumptions made, actual results may differ from estimated results.</p>
CY2023	us-gaap	Payments To Suppliers PaymentsToSuppliers	54870	cny
CY2024	us-gaap	Payments To Suppliers PaymentsToSuppliers	2724906	cny
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Concentrations of Credit Risk and Significant Suppliers</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject Lakeshore Group to concentration of credit risk consist of cash. Lakeshore Group mitigates this risk by maintaining its cash with high quality, accredited financial institutions. As of March 31, 2024, Lakeshore Group’s cash was deposited at more than two financial institutions and it did not have any foreign currency exchange contracts, option contracts or other hedging arrangements. Lakeshore Group has not experienced any losses on its deposits of cash and does not believe that it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lakeshore Group’s sales are made primarily to Centers for Disease Control and Prevention (“CDCs”) in China. Lakeshore Group does not have a concentration of its revenue and accounts receivable with specific customers. As of March 31, 2024 and 2023, there was no customer which accounted for more than 10% of Lakeshore Group’s accounts receivable balance. During the years ended March 31, 2024, 2023 and 2022, there were no customers that accounted for more than 10% of Lakeshore Group’s net revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Details of Lakeshore Group’s top 5 vendors accounting for total purchases are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor D</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">36,567,150</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,153,932</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20.2</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor I</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,635,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,767,467</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,260,918</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,869,051</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor J</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,090,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,422,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.6</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor G</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,544,080</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,345,184</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">89,098,203</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,557,886</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">49.2</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">48,006,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,986,117</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">37.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,178,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,208,772</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,053,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,463,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor H</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,846,214</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">996,291</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor C</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,746,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">690,736</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.7</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">84,830,864</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,344,960</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66.9</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">35,172,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,540,508</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20.9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,227,146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,556,181</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9.6</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vendor C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,995,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,574,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,426,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,169,859</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.4</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor E</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,621,300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,043,020</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,442,385</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,884,060</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">44.7</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Details of Lakeshore Group’s key vendors accounting for accounts payable are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Vendor D</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,408,375</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">480,391</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">5.0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,408,375</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">480,391</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(RMB)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(US$)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Vendor A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,220,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">468,589</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">4.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Vendor F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vendor H</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,346</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,236,538</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">470,996</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lakeshore Group’s business operation has been, and may continue to be, negatively affected by the outbreak of COVID-19. While many of the restrictions on movements within China have been relaxed, there is great uncertainty around the future of the COVID-19 outbreak and how it will impact Lakeshore Group’s operations. If the outbreak persists or escalates, Lakeshore Group may be subject to further negative impact on business operations and financial condition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024	lsb	Percentage Of Late Fees Related To Social Security Insurance PercentageOfLateFeesRelatedToSocialSecurityInsurance	0.0005	pure
CY2024Q1	lsb	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	10700000	cny
CY2023Q1	lsb	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	9900000	cny
CY2022Q1	lsb	Late Fees For Its Liabilities Related To Social Security Insurance LateFeesForItsLiabilitiesRelatedToSocialSecurityInsurance	9500000	cny
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	500000	cny
CY2024Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	70472	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	487418616	cny
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	473515321	cny
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	66739298	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24366824	cny
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29354030	cny
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4137284	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	463051792	cny
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	444161291	cny
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	62602014	usd
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8530951	cny
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13615875	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	24366824	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3434366	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5084924	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10750949	cny
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4987206	cny
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	702918	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13615875	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	24366824	cny
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29354030	cny
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4137284	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	50453180	cny
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	68613919	cny
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	9670743	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	61275177	cny
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	49083445	cny
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	6918033	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	78432041	cny
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	153879476	cny
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21688439	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	4779446	cny
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	68154238	cny
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	9605953	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	185380952	cny
CY2024Q1	us-gaap	Inventory Net InventoryNet	203422602	cny
CY2024Q1	us-gaap	Inventory Net InventoryNet	28671262	usd
CY2021Q1	us-gaap	Inventory Adjustments InventoryAdjustments	41301797	cny
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	5503029	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	4779446	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	673636	usd
CY2022	lsb	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	4393629	cny
CY2023	lsb	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	3670046	cny
CY2024	lsb	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	68221016	cny
CY2024	lsb	Additions To Inventory Adjustments AdditionsToInventoryAdjustments	9615365	usd
CY2022	lsb	Inventories Written Off InventoriesWrittenOff	40192397	cny
CY2023	lsb	Inventories Written Off InventoriesWrittenOff	4393629	cny
CY2024	lsb	Inventories Written Off InventoriesWrittenOff	4846224	cny
CY2024	lsb	Inventories Written Off InventoriesWrittenOff	683048	usd
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	5503029	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	4779446	cny
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	68154238	cny
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	9605953	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	780512580	cny
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	789019434	cny
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	111207813	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	178864241	cny
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	205542536	cny
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28970054	usd
CY2023Q1	lsb	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	29891896	cny
CY2024Q1	lsb	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	110128892	cny
CY2024Q1	lsb	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	15522043	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	571756443	cny
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	473348006	cny
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66715716	usd
CY2014Q1	lsb	Accumulated Impairment Property Plant And Equipment AccumulatedImpairmentPropertyPlantAndEquipment	29900000	cny
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4339791	cny
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4043044	cny
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	569844	usd
CY2023Q1	lsb	Staff Advances Current StaffAdvancesCurrent	606859	cny
CY2024Q1	lsb	Staff Advances Current StaffAdvancesCurrent	174810	cny
CY2024Q1	lsb	Staff Advances Current StaffAdvancesCurrent	24638	usd
CY2023Q1	lsb	Staffs Social Security Current StaffsSocialSecurityCurrent	252090	cny
CY2024Q1	lsb	Staffs Social Security Current StaffsSocialSecurityCurrent	158872	cny
CY2024Q1	lsb	Staffs Social Security Current StaffsSocialSecurityCurrent	22392	usd
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	4249718	cny
CY2024Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1598117	cny
CY2024Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	225246	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	178699	cny
CY2023Q1	us-gaap	Other Receivables OtherReceivables	901355	cny
CY2024Q1	us-gaap	Other Receivables OtherReceivables	1395246	cny
CY2024Q1	us-gaap	Other Receivables OtherReceivables	196652	usd
CY2023Q1	lsb	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets	115743	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10412769	cny
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7370089	cny
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1038772	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	157225338	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	157225338	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22160019	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	79168546	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	85980002	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12118393	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	78056792	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71245336	cny
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10041626	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	193736563	cny
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	318540732	cny
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	44896509	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	293790596	cny
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	98983780	cny
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	13951202	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	487527159	cny
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	417524512	cny
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	58847711	usd
CY2023Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0475	pure
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2900000	cny
CY2024Q1	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	4400000	cny
CY2024Q1	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	600000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	900000	cny
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	100000	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	47500000	cny
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	32000000	cny
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	2800000	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11132428	cny
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7275367	cny
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1025422	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4753547	cny
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5156540	cny
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	726785	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6348890	cny
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1783593	cny
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	251387	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4594967	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5002684	cny
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	5252026	cny
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	740243	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4587894	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3349856	cny
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	5272746	cny
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	743164	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5386340	cny
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	759174	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1813582	cny
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	255614	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7199922	cny
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1014788	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	259789	cny
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36616	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6940133	cny
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	978172	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	55188497	cny
CY2024Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	59297454	cny
CY2024Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	8357640	usd
CY2023Q1	lsb	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	87567459	cny
CY2024Q1	lsb	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	114508487	cny
CY2024Q1	lsb	Accrued Promotional Service Fee Current AccruedPromotionalServiceFeeCurrent	16139322	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	379595	cny
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	3012548	cny
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	424602	usd
CY2023Q1	lsb	Accrued Late Fees Current AccruedLateFeesCurrent	9927056	cny
CY2024Q1	lsb	Accrued Late Fees Current AccruedLateFeesCurrent	10683258	cny
CY2024Q1	lsb	Accrued Late Fees Current AccruedLateFeesCurrent	1505745	usd
CY2023Q1	lsb	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	47579463	cny
CY2024Q1	lsb	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	20413798	cny
CY2024Q1	lsb	Payable For Property Plant And Equipment Current PayableForPropertyPlantAndEquipmentCurrent	2877209	usd
CY2023Q1	lsb	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	49976200	cny
CY2024Q1	lsb	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	53515233	cny
CY2024Q1	lsb	Cdc Transportation And Storage Fee Current CdcTransportationAndStorageFeeCurrent	7542668	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	108795884	cny
CY2024Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	119313398	cny
CY2024Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	16816547	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5121970	cny
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7346813	cny
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1035492	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6055245	cny
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9909655	cny
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1396710	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6945275	cny
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10737325	cny
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1513366	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	377536644	cny
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	408737969	cny
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	57609301	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	2300000	cny
CY2024Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	14600000	cny
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47390831	cny
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	51990629	cny
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7327784	usd
CY2023Q1	lsb	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	7179828	cny
CY2024Q1	lsb	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	6656034	cny
CY2024Q1	lsb	Accrued Social Security Insurance Current AccruedSocialSecurityInsuranceCurrent	938130	usd
CY2023Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	617838	cny
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	650791	cny
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	91726	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	55188497	cny
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	59297454	cny
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8357640	usd
CY2024	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	4500000	cny
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8792389	cny
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4458844	cny
CY2024	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	214459	cny
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4548004	cny
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	641015	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2024Q1	lsb	Ordinary Shares Equals Or Exceeds Per Share OrdinarySharesEqualsOrExceedsPerShare	10
CY2024	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	(1) may be less than the value the holders would have received if they had exercised their Warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the warrants, including because the number of Lakeshore Biopharma Ordinary Shares received is capped at 0.361 Lakeshore Biopharma Ordinary Shares per warrant (subject to adjustment) irrespective of the remaining life of the warrants
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P30D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.3156
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.3156
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.402
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3253565	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.402
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3253565	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1900000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.65
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	200000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.72
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7764448	cny
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3505001	cny
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9789686	cny
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1379801	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	143750	shares
CY2023Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	20000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.1826	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.36	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.1332	pure
CY2022	lsb	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	0.0456	pure
CY2023	lsb	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	0.0872	pure
CY2024	lsb	Effective Income Tax Rate Reconciliation Effect Of Prc Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPrcPreferentialTaxRate	-0.0339	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.332	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.255	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.0997	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0006	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.0488	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.0079	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.0477	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4447	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2323	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1831	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0491	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0078	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0476	pure
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	716917	cny
CY2024Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10223137	cny
CY2024Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1440893	usd
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1769405	cny
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	13542899	cny
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1908795	usd
CY2023Q1	lsb	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	3296223	cny
CY2024Q1	lsb	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	2951867	cny
CY2024Q1	lsb	Deferred Tax Assets Deferred Government Grants DeferredTaxAssetsDeferredGovernmentGrants	416049	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39366020	cny
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	81220037	cny
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11447503	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39366020	cny
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81220037	cny
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11447503	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5782545	cny
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	26717903	cny
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3765737	usd
CY2023Q1	lsb	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiarie DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiarie	-3876964	cny
CY2024Q1	lsb	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiarie DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiarie	-3083714	cny
CY2024Q1	lsb	Deferred Tax Liabilities Fair Value Adjustments Arising From Historical Acquisition Of Subsidiarie DeferredTaxLiabilitiesFairValueAdjustmentsArisingFromHistoricalAcquisitionOfSubsidiarie	-434632	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3876964	cny
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3083714	cny
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	434632	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1905581	cny
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23634189	cny
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3331105	usd
CY2024	lsb	Government Assistance Addition Received That Were Deferred GovernmentAssistanceAdditionReceivedThatWereDeferred	3600000	cny
CY2023	lsb	Government Assistance Addition Received That Were Deferred GovernmentAssistanceAdditionReceivedThatWereDeferred	4000000	cny
CY2023Q1	lsb	Deferred Government Grants DeferredGovernmentGrants	25902208	cny
CY2024Q1	lsb	Deferred Government Grants DeferredGovernmentGrants	22295638	cny
CY2024Q1	lsb	Deferred Government Grants DeferredGovernmentGrants	3142443	usd
CY2023Q1	lsb	Current Portion CurrentPortion	2295701	cny
CY2024Q1	lsb	Current Portion CurrentPortion	2015693	cny
CY2024Q1	lsb	Current Portion CurrentPortion	284100	usd
CY2023Q1	lsb	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	23606507	cny
CY2024Q1	lsb	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	20279945	cny
CY2024Q1	lsb	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	2858343	usd
CY2024Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	120451701	cny
CY2024Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	16976984	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	95269762	shares
CY2024Q2	lsb	Aggregate Amount Of Payment AggregateAmountOfPayment	919000000	cny
CY2024Q2	us-gaap	Payments For Fees PaymentsForFees	721000000	cny
CY2024Q2	lsb	Aggregate To Repay AggregateToRepay	723000000	cny
CY2024Q2	lsb	Actual Frozen Amount ActualFrozenAmount	902000000	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024	lsb	Subsidiaries Exceed Percentage SubsidiariesExceedPercentage	0.25	pure
CY2024	dei	Entity Address Country EntityAddressCountry	CN
CY2024	lsb	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax		cny
CY2024	lsb	Late Fees Related To Taxes Other Than Income Tax LateFeesRelatedToTaxesOtherThanIncomeTax		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2024	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		cny
CY2024	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.71
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.35
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.05
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106923121	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106923121	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61785466	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61827883	shares
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		cny
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		cny
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		cny
CY2024	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		cny
CY2024	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		cny
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2022	lsb	Proceeds From Business Combination ProceedsFromBusinessCombination		cny
CY2024	lsb	Proceeds From Business Combination ProceedsFromBusinessCombination		cny
CY2024	lsb	Proceeds From Business Combination ProceedsFromBusinessCombination		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2024	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2024	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		cny
CY2024	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
CY2022	lsb	Equity Transaction From Warrants EquityTransactionFromWarrants		cny
CY2024	lsb	Equity Transaction From Warrants EquityTransactionFromWarrants		cny
CY2024	lsb	Equity Transaction From Warrants EquityTransactionFromWarrants		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		cny
CY2024	us-gaap	Stock Issued1 StockIssued1		cny
CY2024	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	us-gaap	Payments To Suppliers PaymentsToSuppliers		cny
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance		cny
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance		usd
CY2024Q1	lsb	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets		cny
CY2024Q1	lsb	Allowance On Prepaid Expenses And Other Current Assets AllowanceOnPrepaidExpensesAndOtherCurrentAssets		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001946399

Files In Submission

Name	View Source	Status
0001213900-24-069344-index-headers.html	Edgar Link	pending
0001213900-24-069344-index.html	Edgar Link	pending
0001213900-24-069344.txt	Edgar Link	pending
0001213900-24-069344-xbrl.zip	Edgar Link	pending
ea0210595-20f_lakeshore.htm	Edgar Link	pending
ea021059501ex1-1_lakeshore.htm	Edgar Link	pending
ea021059501ex11-1_lakeshore.htm	Edgar Link	pending
ea021059501ex11-2_lakeshore.htm	Edgar Link	pending
ea021059501ex12-1_lakeshore.htm	Edgar Link	pending
ea021059501ex12-2_lakeshore.htm	Edgar Link	pending
ea021059501ex13-1_lakeshore.htm	Edgar Link	pending
ea021059501ex13-2_lakeshore.htm	Edgar Link	pending
ea021059501ex15-1_lakeshore.htm	Edgar Link	pending
ea021059501ex15-2_lakeshore.htm	Edgar Link	pending
ea021059501ex15-3_lakeshore.htm	Edgar Link	pending
ea021059501ex2-1_lakeshore.htm	Edgar Link	pending
ea021059501ex2-2_lakeshore.htm	Edgar Link	pending
ea021059501ex2-3_lakeshore.htm	Edgar Link	pending
ea021059501ex4-1_lakeshore.htm	Edgar Link	pending
ea021059501ex4-3_lakeshore.htm	Edgar Link	pending
ea021059501ex4-4_lakeshore.htm	Edgar Link	pending
ea021059501ex4-5_lakeshore.htm	Edgar Link	pending
ea021059501ex8-1_lakeshore.htm	Edgar Link	pending
ea021059501ex97-1_lakeshore.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-3_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
ea0210595-20f_lakeshore_htm.xml	Edgar Link	completed
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
lsb-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lsb-20240331_cal.xml	Edgar Link	unprocessable
lsb-20240331_pre.xml	Edgar Link	unprocessable
lsb-20240331_def.xml	Edgar Link	unprocessable
lsb-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb

2024 Q1 Form 20-F Financial Statement

#000121390024069344 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSB LakeShore Biopharma Co., Ltd. Stock $lsb

2024 Q1 Form 20-F Financial Statement

#000121390024069344 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSB
LakeShore Biopharma Co., Ltd. Stock $lsb